| Previous Close | 50.84 |
| Open | 50.81 |
| Bid | 50.69 x 900 |
| Ask | 50.70 x 1300 |
| Day's Range | 50.47 - 50.94 |
| 52 Week Range | 37.38 - 51.13 |
| Volume | 2,602,594 |
| Avg. Volume | 6,362,514 |
| Market Cap | 88.01B |
| Beta | 1.54 |
| PE Ratio (TTM) | 52.78 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.06 (2.08%) |
| Ex-Dividend Date | 2017-07-12 |
| 1y Target Est | N/A |
- Market Realist•4 hours ago
Abiomed Expects to Expand Its Presence in This Space
Abiomed is primarily focused on the growth opportunity in the protected PCI area, a procedure that is applicable for patients with coronary artery disease.
- Market Realist•3 days ago
Abiomed Impella Quality Program Will Boost Demand in Fiscal 2018
To improve clinical outcomes and increase the number of patients treated in the United States using Impella, Abiomed has launched the Abiomed Impella Quality Program.
- Market Realist•3 days ago
Behind the Major Drivers of JNJ’s Medical Device Growth
Johnson & Johnson (JNJ) reported Medical Devices segment sales of ~$6.7 billion in 2Q17, compared with $6.4 billion in 2Q16.
